No abstract available
MeSH terms
-
Administration, Topical
-
Adrenergic alpha-Agonists / administration & dosage*
-
Brimonidine Tartrate
-
Color Vision Defects / drug therapy
-
Color Vision Defects / etiology
-
Humans
-
Ophthalmic Solutions
-
Optic Neuropathy, Ischemic / complications
-
Optic Neuropathy, Ischemic / drug therapy*
-
Quinoxalines / administration & dosage*
-
Retrospective Studies
-
Treatment Failure
-
Vision Disorders / drug therapy
-
Vision Disorders / etiology
-
Visual Acuity
Substances
-
Adrenergic alpha-Agonists
-
Ophthalmic Solutions
-
Quinoxalines
-
Brimonidine Tartrate